The extraordinary breakthrough in how ‘killer’ CD8 + T cells – the body’s ‘army of hitmen’ tasked with taking out new viruses – retain memories of virus strains they encounter was published in the prestigious Nature Communications journal this week (May 13).
University of Melbourne’s Associate Professor Katherine Kedzierska explained how the Australia-Sino collaboration began during the first outbreak of the avian-derived H7N9 virus in China in 2013.
That contagion saw 99% of people infected hospitalised, with a 30% mortality rate. Patient zero was an elderly man who caught the virus from a chicken his wife asked him to buy at the local live bird market.
“We’d never seen anything like H7N9,” Associate Professor Kedzierska said. “The virus was infecting more people rapidly and nobody had immunity. Thankfully, we did manage to contain the virus but we knew we had come face-to-face with a potential pandemic that could kill millions of people around the world if the virus became able to spread between humans,” she said.
“After collecting samples from infected patients we found that people who couldn’t make these T cell flu assassins were dying. These findings lead to the potential of moving from vaccines for specific influenza strains toward developing a protection, which is based on T-cells,” she said.
“From the 30% mortality rate in China we knew the clock was ticking on the situation. Had the contagion spread broken out globally, we’re talking about a history-altering event on the Spanish Flu scale. As it turns out, boosting the T cell adaptive memory capacity is our way in,” Associate Prof Kedzierska said.
“Our extraordinary breakthrough could lead to the development of a vaccine component that can protect against all new influenza viruses, with the potential for future development of a one-off universal flu vaccine shot,” she said. “This work will also help clinicians to make early predictions of how well a patient’s immune system will respond to viruses so they can manage early interventions such as artificial ventilation more effectively, particularly in cases where the patient is at risk of dying.”
The Latest on: Flu vaccine
via Google News
The Latest on: Flu vaccine
- Artikel-artikel mengenai Flu vaccine 2019 on April 17, 2019 at 1:25 pm
The 2018 flu season was mild, while 2017 was a particularly bad year. It's impossible to predict what the 2019 flu season has in store, but we've seen more cases so far this year than usual. […]
- UW researchers developing permanent flu vaccine score $45M donation on April 17, 2019 at 12:49 pm
The donation comes from The Audacious Project, an organization that looks to fund projects that can effect positive change on a global scale. UW’s Institute for Protein Design certainly seems to ... […]
- $12 million grant renewal for flu vaccine research on April 17, 2019 at 10:18 am
The National Institutes of Health has awarded the Stanford Institute for Immunity, Transplantation and Infection a five-year, $12 million renewal of a grant for the study of how people respond to ... […]
- Manufacturer to Produce Cell-Based Flu Vaccine for Next Season on April 17, 2019 at 9:58 am
Influenza protection company Seqirus has announced the filing of an annual strain update with the FDA. The update includes the company’s decision to manufacture their cell-based influenza vaccine ... […]
- Mystery illness at Perak school turns out to be Influenza A(H1N1) on April 17, 2019 at 3:21 am
IPOH (Bernama): Claims of a mysterious illness in Sekolah Tuanku Abdul Rahman (STAR) here that went viral on social media Tuesday (April 16) are not true as it is just an Influenza A(H1N1) infection, ... […]
- Swine Influenza Vaccines 2019 Global Trends, Market Size, Share, Status, SWOT Analysis and Forecast to 2025 on April 17, 2019 at 12:42 am
The global Swine Influenza Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to ... […]
- Global Swine Influenza Vaccines Market Prospective Growth, Opportunities, Top Key Players and Forecast to 2025 on April 17, 2019 at 12:35 am
Apr 17, 2019 (Heraldkeeper via COMTEX) -- WiseGuyRerports.com Presents "Global Swine Influenza Vaccines Market Insights, Forecast to 2025" New Document to its Studies Database The global Swine ... […]
- UW institute developing lifetime flu vaccine gets $45 million award on April 16, 2019 at 5:13 pm
A universal flu vaccine that immunizes someone for a lifetime. Smart proteins that can identify cancerous cells. Nanomaterial proteins that self-assemble and could be used for solar energy. These are ... […]
- First-In-Human Trial Begins On Universal Flu Vaccine, Older Adults Still Encouraged To Vaccinate on April 16, 2019 at 7:20 am
As researchers at the National Institutes of Health (NIH) begin clinical trials on a “universal” flu vaccine this month, older adults are reminded that immunizations aren’t just for children anymore. ... […]
- Seqirus Announces Further Advances in Cell-Based Influenza Vaccine Technology on April 15, 2019 at 5:30 am
SUMMIT, N.J., April 15, 2019 /PRNewswire/ -- Seqirus, a leading innovator in influenza protection, today announced it will file an Annual Strain Update with the U.S. Food and Drug Administration (FDA) ... […]
via Bing News